After two successful previous editions, the 3rd edition of Leiden Drug Development Conference (LDDC) is set to take place on 19 September 2024. Organized by LUMC, Leiden University, Johnson & Johnson, and TNO, LDDC-3 promises to be a groundbreaking event.
In an era of rapid technological advancement, artificial intelligence (AI) is transforming industries worldwide. At LDDC-3, we have decided to dedicate the entire conference to AI’s impact on drug development, manufacturing, and healthcare. Our program covers a wide spectrum, from advanced interaction modeling of 3D protein structures to extracting relevant insights from federated patient data. We will also address the ethical and practical implications of AI applications.
Deze website maakt gebruik van cookies. Cookies zijn tekstbestanden die op de computer worden geplaatst wanneer websites worden bezocht. Ze worden veel gebruikt om websites efficiënt te laten werken en om informatie te verstrekken aan de eigenaren van de website. Hieronder kan aangegeven worden of u de cookies accepteert.